BR112012009309A2 - combined vaccine, use of an immunogenic amount of microorganism cells, method for preparing a combined vaccine, and kit of parts - Google Patents

combined vaccine, use of an immunogenic amount of microorganism cells, method for preparing a combined vaccine, and kit of parts

Info

Publication number
BR112012009309A2
BR112012009309A2 BR112012009309A BR112012009309A BR112012009309A2 BR 112012009309 A2 BR112012009309 A2 BR 112012009309A2 BR 112012009309 A BR112012009309 A BR 112012009309A BR 112012009309 A BR112012009309 A BR 112012009309A BR 112012009309 A2 BR112012009309 A2 BR 112012009309A2
Authority
BR
Brazil
Prior art keywords
combined vaccine
vaccine
kit
parts
preparing
Prior art date
Application number
BR112012009309A
Other languages
Portuguese (pt)
Other versions
BR112012009309B1 (en
Inventor
Brian Sheehan
Laura Labrie
Won Fong Sian
Yeng Sheng Lee
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of BR112012009309A2 publication Critical patent/BR112012009309A2/en
Publication of BR112012009309B1 publication Critical patent/BR112012009309B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

vacina combinada, uso de uma quantidade imunogênica de células de microrganismo, método para a preparação de uma vacina combinada, e, kit de partes. a presente invenção diz respeito a uma vacina combinada para a proteção de peixe contra infecção estreptocócia, o uso de estreptococos para a fabricação de uma tal vacina, a métodos para a preparação de uma tal vacina combinada e a um kit de partes que compreendem uma tal vacina.combined vaccine, use of an immunogenic amount of microorganism cells, method for preparing a combined vaccine, and parts kit. The present invention relates to a combined vaccine for the protection of fish against streptococcal infection, the use of streptococci for the manufacture of such a vaccine, methods for the preparation of such a combined vaccine and a kit of parts comprising such a vaccine. vaccine.

BR112012009309-6A 2009-10-19 2010-10-18 COMBINED VACCINE, USE OF MICRO-ORGANISMS CELLS, METHOD FOR THE PREPARATION OF A COMBINED VACCINE, AND, KIT OF PARTS BR112012009309B1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP09173367.5 2009-10-19
EP09173367 2009-10-19
US25325609P 2009-10-20 2009-10-20
US61/253256 2009-10-20
PCT/EP2010/065611 WO2011048041A1 (en) 2009-10-19 2010-10-18 Streptococcal combi-vaccine

Publications (2)

Publication Number Publication Date
BR112012009309A2 true BR112012009309A2 (en) 2016-06-07
BR112012009309B1 BR112012009309B1 (en) 2021-10-05

Family

ID=41403314

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012009309-6A BR112012009309B1 (en) 2009-10-19 2010-10-18 COMBINED VACCINE, USE OF MICRO-ORGANISMS CELLS, METHOD FOR THE PREPARATION OF A COMBINED VACCINE, AND, KIT OF PARTS

Country Status (4)

Country Link
CN (2) CN107648600A (en)
BR (1) BR112012009309B1 (en)
TW (1) TWI495478B (en)
WO (1) WO2011048041A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020177005A1 (en) * 2019-03-04 2020-09-10 Centrovet Limitada Bivalent vaccine against streptococcus iniae and streptococcus agalactiae
CN117018173A (en) * 2023-10-10 2023-11-10 西北农林科技大学深圳研究院 Tagetes tilapia streptococcus bigeminal subunit nano vaccine, preparation and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8205892D0 (en) 1982-10-18 1982-10-18 Bror Morein IMMUNOGENT MEMBRANE PROTEIN COMPLEX, SET FOR PREPARATION AND USE THEREOF
SE8405493D0 (en) 1984-11-01 1984-11-01 Bror Morein IMMUNOGENT COMPLEX AND KITCHEN FOR PREPARING IT AND USING IT AS IMMUNOSTIMENTING AGENTS
US6379677B1 (en) 2000-02-25 2002-04-30 The United States Of America As Represented By The Secretary Of The Department Of Agriculture Streptococcus iniae vaccine
US7204993B2 (en) 2004-03-18 2007-04-17 The United States Of America As Represented By The Secretary Of Agriculture Streptococcus agalactiae vaccine
WO2007138036A1 (en) * 2006-05-30 2007-12-06 Intervet International B.V. Vaccine against rickettsia-like organisms
EP2104512A2 (en) * 2006-12-21 2009-09-30 Emergent Product Development UK Limited Streptococcus proteins, and their use in vaccination

Also Published As

Publication number Publication date
CN107648600A (en) 2018-02-02
TWI495478B (en) 2015-08-11
WO2011048041A1 (en) 2011-04-28
BR112012009309B1 (en) 2021-10-05
TW201119671A (en) 2011-06-16
CN102740878A (en) 2012-10-17

Similar Documents

Publication Publication Date Title
CO6331297A2 (en) NEW ADVANCING COMPOSITIONS
CO6511229A2 (en) METHODS TO REDUCE VIRIED ACTIVITY IN PCV-2 COMPOSITIONS AND PCV-2 COMPOSITIONS WITH IMPROVED IMMUNOGEICITY
CO6751260A2 (en) OMV-based vaccines against burkholderia infections
MX357906B (en) Crystalline complex of 1-cyano-2-(4-cyclopropyl-benzyl)-4-(ãŸ- d-glucopyranos-1-yl)-benzene, methods for its preparation and the use thereof for preparing medicaments.
BR112012032008A2 (en) s100a4 antibodies and therapeutic uses thereof
BR112013025424A2 (en) processes for producing an immunogenic composition, and for manufacturing a vaccine, and immunogenic composition
BR112014032636A2 (en) ATENUATED STREPTOCOCCUS SUIS VACCINES AND PRODUCTION METHODS AND THEIR USES
BRPI0821240A2 (en) mutant forms of streptolysin the
HN2012000217A (en) Spirocyclic amide derivatives
BR112015021523A8 (en) composition of a vaccine against acellular pertussis, and uses of the composition and antigens of bordetella pertussis
MX352553B (en) Oral care composition comprising an amadori compound.
BR112012030794A2 (en) new immunoadjuvant compounds and their uses
BR112012024224A2 (en) flavivirus host band mutations and their use.
BR112012009309A2 (en) combined vaccine, use of an immunogenic amount of microorganism cells, method for preparing a combined vaccine, and kit of parts
ECSP088907A (en) VACCINE AGAINST RICKETTSIA SIMILAR ORGANISMS
ECSP099066A (en) ESTREPTOCOCICA COMBINED VACCINE
CR20150246A (en) IMMUNOGENIC COMPOSITION AGAINST HYDROPHILA AIRPORTS
CL2011001097A1 (en) Vaccine composition comprising e. meleagrimitis 2 and meleagrimitis 1; use of said vaccine to immunize a turkey against cocciodiosis; method to identify an eimeria isolate as an eimeria meleagrimitis 2; and amplification kit by pcr.
BR112015002984A2 (en) composition, vaccine to protect an animal against infection with leptospira bacteria, and use of citric acid.
BRPI0713274A2 (en) combination of vaccines for the protection of fish against streptococcal infection, and method for preparing a combination of vaccines
AR089868A1 (en) VECTOR OF EIMERIA FOR CAMPYLOBACTER JEJUNI
BR112015024882B8 (en) Composition, vaccine against rhipicephalus ticks, methods for preparing a composition and a vaccine against rhipicephalus ticks, use of bm86 protein and a subolesin protein, and, kit of parts
EP2501405A4 (en) Compositions, methods and uses for poxvirus elements in vaccine constructs
MY176015A (en) Immunogenic composition against aeromonas hydrophila
GT200600113A (en) VACCINE FORMULA

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/10/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.